Metrics as of 10/14/2026, 08:39 AM (Berlin time), refresh in progress.
MediciNova Stock
MediciNova, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Yuichi Iwaki
- Employees
- 6
- Market cap
- $73 M
- IPO
- 08/12/2006
MediciNova, Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative small molecule therapies for severe illnesses where current treatments are insufficient within the United States. Its robust development pipeline features MN-166 (ibudilast), an oral agent with both anti-inflammatory and…
MediciNova stock: price history
1D
-0.7%
1W
-7.5%
1M
-20.3%
6M
+4.2%
YTD
+13.7%
1Y
+19.2%
2Y
-15.8%
5Y
-61.0%
10Y
-77.8%
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~2% weaker price swings than usual
Ask the agents about MediciNova
Analyst assessment of MediciNova
PRICE TARGET LOW
US$6.00
CONSENSUS
US$6.00
MEDIAN
US$6.00
PRICE TARGET HIGH
US$6.00
0
STRONG BUY
4
BUY
0
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 04/05/2026
MediciNova stock metrics
P/E
-6.86
P/B
1.97
EV/EBITDA
-4.39
RETURN ON EQUITY
-6.2%
NET MARGIN
-504.8%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
85.8%
FLOAT SHARES
42,255,947
AVG. DAILY VOLUME (30D)
650,274
Insider transactions (SEC)
3D Investment Partners Pte. Ltd.
Institutional holders
Comparable stocks
Frequently asked questions about MediciNova stock
What does MediciNova do?
MediciNova, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Yuichi Iwaki, the company employs around 6 people.
The IPO was on 08/12/2006; the stock trades on NASDAQ under the ticker MNOV.
What do analysts say about MediciNova stock?
4 analysts rate the stock, the consensus is Buy (as of 04/05/2026).
The average price target is US$6.00, ranging from US$6.00 to US$6.00, with a median of US$6.00.
This is an external assessment, not a statement by Market Jury.
When does MediciNova report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly -2% stronger than usual.
Does MediciNova pay a dividend?
No, MediciNova currently does not pay a dividend.
Which stocks are comparable to MediciNova?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get MediciNova stock analyzed?
Clicking "Analyze stock" lets five strategies assess MediciNova against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.